India's Richest People 2026 edition · 1 director · Source: Hurun India
- #55 Manju D Gupta & family ₹50,000 Cr
Revenue · FY 2025
₹98.57 Cr
▲ 42% YoY
Net loss · FY 2025
₹106.5 Cr
Net margin -108%
EBITDA · FY 2025
-₹65.27 Cr
EBITDA margin -66.2%
Authorised capital
₹220 Cr
Registered with MCA
Paid-up capital
₹78.97 Cr
Issued & subscribed
Company age
15 yrs
Est. 2011
Employees · EPFO
556
Provident fund records
Directors on board
4
As per MCA filings
About Lupin Diagnostics Limited
Data last updated:
Lupin Diagnostics Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Lupin Limited. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 17 March 2011 and has been in existence for over 15 years.
Its director Manju D Gupta and family are #55 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2011PLC214885. Its GSTIN is 27AABCL9756A1ZH (Maharashtra). The company holds 15 GST registrations, of which 11 are active.
The company has an authorised share capital of ₹220 Cr and a paid-up capital of ₹78.97 Cr. It was formerly known as Lupin Healthcare Limited. It is led by directors including Nilesh Deshbandhu Gupta (Managing Director) and Swaminathan Ramesh.
Its last annual general meeting (AGM) was held on 30 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹98.57 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net loss of ₹106.5 Cr (net margin -108%) and EBITDA of -₹65.27 Cr (EBITDA margin -66.2%). Revenue has grown at a compounded annual rate (CAGR) of 172% over three years and 226% over five years.
The company has about 556 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lupin Diagnostics. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 8 deals on record (5 funding rounds, 3 convertible or debt financings), with disclosed funding of ₹356.17 Cr; the latest was in December 2024. Its 4 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 2 larger and 2 smaller; the largest is GHL Pharma & Diagnostic Private Limited with revenue of ₹106.96 Cr. The company has 9 MSME Form 1 returns on record between 2022 and 2024, listing 405 overdue payments to 61 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lupindiagnostics.com.
Company details
CIN U24100MH2011PLC214885
Registration Number 214885
Incorporation Date 17 March 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 July 2025
Date of Balance Sheet 31 March 2025
Parent Company Lupin Limited
Compliance Status Active Compliant
Key People
Nilesh Deshbandhu Gupta Managing Director Swaminathan Ramesh Director Manju Deshbandhu Gupta Director Recognitions & Rankings of Lupin Diagnostics
Contact details
Lupin Diagnostics Limited's registered office is in Mumbai, Maharashtra. Its website is lupindiagnostics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressKalpataru Inspire 3rd Floor Off Western Express Highway Santacuz(Ea, St)., Mumbai, Maharashtra, India – 400055
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Lupin Diagnostics Limited, buy the company report.
Comprehensive company report
Lupin Diagnostics Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Lupin Diagnostics operates one associated brand: Lupin Diagnostics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates a chain of pathology laboratory centers for diagnostic services. | lupindiagnostics.com |
Business activity
The main business activity of Lupin Diagnostics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Lupin Diagnostics Limited, buy the company report.
Financials of Lupin Diagnostics Limited
FY 2025 filings availableLupin Diagnostics Limited reported revenue of ₹98.57 Cr (up 42% YoY) for FY 2025.
Revenue · FY 2025
₹98.57 Cr ▲ 42%
Net loss · FY 2025
₹106.5 Cr margin -108%
EBITDA · FY 2025
-₹65.27 Cr margin -66.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 172%
5 years · compounded
▲ 226%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 44%
5 years · compounded
▼ 202%
Revenue has grown at a compounded annual rate (CAGR) of 226% over five years, including 42% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹65.27 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹106.5 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -66.2% | ||||
| Net Profit Margin | -108% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lupin Diagnostics Limited, buy the company report.
Board of directors of Lupin Diagnostics Limited
Lupin Diagnostics has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swaminathan Ramesh Also directs: Lupin Limited, Lupin Manufacturing Solutions Limited, Lupin Life Sciences Limited and 4 more | Director | 28 Nov 2023 | 2 Years 10 Months | Current |
| Nilesh Deshbandhu Gupta Also directs: Lupin Limited, Lupin Manufacturing Solutions Limited, Polynova Industries Limited and 5 more | Managing Director | 26 Aug 2011 | 15 Years 1 Months | Current |
| Manju Deshbandhu Gupta Also directs: Lupin Limited, Lupin Manufacturing Solutions Limited, Polynova Industries Limited and 1 more | Director | 12 May 2022 | 4 Years 5 Months | Current |
| Rajeev Sibal | Director | 15 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Lupin Diagnostics Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| GHL Pharma & Diagnostic Private Limited | ₹106.96 Cr (FY 2025) | 392.0% | Delhi, India | |||
| Datar Cancer Genetics Private Limited | ₹102.27 Cr (FY 2025) | 31.0% | Nashik, Maharashtra, India | |||
| Lupin Diagnostics Limitedthis company | ₹98.57 Cr (FY 2025) | -₹106.5 Cr | -108% | 42.0% | 556 | Mumbai, Maharashtra, India |
| Oncquest Laboratories Limited | ₹97.99 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Accuprobe Healthcare and Diagnostics Private Limited | ₹94.78 Cr (FY 2025) | 35.0% | Delhi, India |
To see the full peer comparison of Lupin Diagnostics Limited, buy the company report.
Auditor
Lupin Diagnostics Limited is audited by For B S R & Co. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| For B S R & Co. LLP | FY 2023 | 101248W/W-100022 |
Shareholding
The shareholding of Lupin Diagnostics Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lupin Diagnostics Limited, buy the company report.
Deals & funding
Lupin Diagnostics Limited has 8 deals on record (5 funding rounds, 3 convertible or debt financings), with disclosed funding of ₹356.17 Cr; the latest was in December 2024.
Total deals
8
Funding rounds
5
Convertible or debt financings
3
Disclosed funding
₹356.17 Cr
Deals on record (2 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2020 | Funding round · Series I | ₹50 Cr | Investors: Lupin Limited |
| Sep 2011 | Funding round | ₹6.17 Cr | Investors: Lupin Limited |
To see the full deal history of Lupin Diagnostics Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Lupin Diagnostics Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Writ petition | Filed against the company by an individual | Pending |
To see the full case history of Lupin Diagnostics Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Lupin Diagnostics Limited has 9 MSME Form 1 returns on record between 2022 and 2024, listing 405 overdue payments to 61 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 61)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Mahasagar Medequip Private Limited | |||
| Srinivasa Medical and Imaging Products Pvt. Ltd. | |||
| Arnk Interiors | |||
| Southern Marketing Agencies |
To see the full MSME payment records of Lupin Diagnostics Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Lupin Diagnostics Limited has a workforce of 556 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
556
Active EPFO establishments
1
Employee growth
62.57%
GST
Lupin Diagnostics has 15 GST registrations: 11 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
15
Active
11
Cancelled / inactive
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCL9756A1ZH | Maharashtra | Active | 19 Nov 2020 |
| 19AABCL9756A1ZE | West Bengal | Active | 11 Oct 2021 |
| 29AABCL9756A1ZD | Karnataka | Active | 14 Feb 2023 |
| 10AABCL9756A2ZV | Bihar | Active | 04 Dec 2024 |
To see the full GST registrations and return filing status of Lupin Diagnostics Limited, buy the company report.
Recent activity
Lupin Diagnostics Limited has 13 board changes on record since 2011: 5 appointments and 8 cessations. The latest: Sunil Makharia ceased to be CFO on 15 Apr 2025.
AGM
Lupin Diagnostics Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records.
Ceased
Sunil Makharia ceased to be CFO.
Filing
Lupin Diagnostics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Amit Kumar Gupta was appointed as Company Secretary.
Ceased
Swaminathan Ramesh ceased to be Additional Director.
Appointed
Swaminathan Ramesh was appointed as Director.
Ceased
Kamal Kishore Sharma ceased to be Director.
Ceased
Manju Deshbandhu Gupta ceased to be Additional Director.
Appointed
Manju Deshbandhu Gupta was appointed as Director.
Ceased
Rajeev Sibal ceased to be Additional Director.
Ceased
Nilesh Deshbandhu Gupta ceased to be Director.
Appointed
Rajeev Sibal was appointed as Director.
4 earlier events are in the company report.
News
Frequently asked questions
Lupin Diagnostics is an active public limited company based in Mumbai, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 17 March 2011 (15+ years old) and is registered under CIN U24100MH2011PLC214885.
Lupin Diagnostics has 4 current directors:
- Nilesh Deshbandhu Gupta - Managing Director
- Swaminathan Ramesh - Director
- Manju Deshbandhu Gupta - Director
- Rajeev Sibal - Director
The latest financial statements of Lupin Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lupin Diagnostics is 27AABCL9756A1ZH, registered in Maharashtra. The company has 15 GST registrations in all, of which 11 are active and 4 are cancelled or inactive. Other active GSTINs include 19AABCL9756A1ZE (West Bengal), 29AABCL9756A1ZD (Karnataka), 10AABCL9756A2ZV (Bihar).
The CIN (Corporate Identification Number) of Lupin Diagnostics is U24100MH2011PLC214885. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lupin Diagnostics has 1 court case on record: 1 filed against it. 1 is pending.
Lupin Diagnostics was incorporated on 17 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Lupin Diagnostics has 8 deals on record (5 funding rounds, 3 convertible or debt financings), with disclosed funding of ₹356.17 Cr; the latest was in December 2024.
The peers of Lupin Diagnostics by revenue are GHL Pharma & Diagnostic Private Limited, Datar Cancer Genetics Private Limited, Oncquest Laboratories Limited, Accuprobe Healthcare and Diagnostics Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).
Sunil Makharia ceased to be CFO on 15 Apr 2025. Amit Kumar Gupta was appointed as Company Secretary on 01 Sep 2024. Swaminathan Ramesh ceased to be Additional Director on 14 Jul 2024. Lupin Diagnostics has 13 board changes on record in total.
Lupin Diagnostics has 9 MSME Form 1 returns on record between 2022 and 2024, listing 405 overdue payments to 61 micro and small suppliers. The latest return was filed on 23 Apr 2024.
Lupin Diagnostics can be reached through the website lupindiagnostics.com. Its registered office is in Mumbai, Maharashtra, India.